Bradley K M, O'Sullivan V T, Soper N D W, Nagy Z, King E M-F, Smith A D, Shepstone B J
Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology and Radcliffe Infirmary, University of Oxford, Oxford, UK.
Brain. 2002 Aug;125(Pt 8):1772-81. doi: 10.1093/brain/awf185.
Reductions in regional cerebral perfusion, particularly in the posterior temporo-parietal lobes, are well recognized in Alzheimer's disease. We set out to correlate perfusion changes, using (99m)Tc-HMPAO single photon emission tomography (SPET), with the pathological stage of Alzheimer's disease. The 'Braak stage' of the distribution of neurofibrillary pathology in post-mortem brains was used to classify SPET scans taken in life from a mixed (dementia and control) elderly population into the entorhinal stage (n = 23 subjects), limbic stage (n = 30 subjects) and neocortical stage (n = 36 subjects) Alzheimer's disease pathology. The SPET scans were then registered to a common, standard Talaraich space, and single template scans produced for each pathological stage. Comparison of these templates revealed an evolution in the pattern of reduction in regional perfusion. Additional comparisons were performed using earlier SPET scans obtained 5 years before death. For comparisons between templates, a threshold of 10% perfusion change was chosen so as to be clinically relevant as well as statistically significant. Reduced perfusion appears between the entorhinal and limbic stages in the anterior medial temporal lobe, subcallosal area, posterior cingulate cortex, precuneus and possibly the supero-anterior aspects of the cerebellar hemispheres. Large posterior temporo-parietal perfusion defects then appear between the limbic and neocortical stages, before finally large frontal lobe perfusion defects. The time course of these perfusion defects appears relatively long, suggesting that perfusion changes may have scope to be a diagnostic aid in staging Alzheimer's disease in life. The reduction in anterior medial temporal lobe perfusion may have future relevance on modern high resolution SPET and PET systems and also perfusion-type MRI sequences.
在阿尔茨海默病中,局部脑灌注减少,尤其是在颞顶叶后部,这是广为人知的。我们旨在利用(99m)Tc - HMPAO单光子发射断层扫描(SPET)将灌注变化与阿尔茨海默病的病理阶段相关联。通过死后大脑中神经原纤维病理分布的“Braak分期”,将来自混合(痴呆和对照)老年人群生前进行的SPET扫描分为内嗅阶段(n = 23名受试者)、边缘阶段(n = 30名受试者)和新皮质阶段(n = 36名受试者)的阿尔茨海默病病理。然后将SPET扫描配准到一个通用的标准Talaraich空间,并为每个病理阶段生成单个模板扫描。这些模板的比较揭示了局部灌注减少模式的演变。还使用了死亡前5年获得的早期SPET扫描进行额外比较。对于模板之间的比较,选择10%灌注变化的阈值,以便在临床上具有相关性且在统计学上具有显著性。在前内侧颞叶、胼胝体下区、后扣带回皮质、楔前叶以及可能的小脑半球上前部,在内嗅和边缘阶段之间出现灌注减少。然后在边缘和新皮质阶段之间出现大的颞顶叶后部灌注缺损,最终出现大的额叶灌注缺损。这些灌注缺损的时间进程似乎相对较长,这表明灌注变化可能有潜力成为生前阿尔茨海默病分期的诊断辅助手段。前内侧颞叶灌注减少可能对现代高分辨率SPET和PET系统以及灌注型MRI序列具有未来相关性。